Ipca Laboratories Shares Drop 2.11%; Among Top Nifty Midcap 150 Losers

• Ipca Laboratories shares declined by 2.11% to Rs 1,421.40 on Tuesday, making it a top loser on the Nifty Midcap 150 index.
• Consolidated quarterly revenue fluctuated, reaching Rs 2,556.50 Crore in September 2025, with net profit at Rs 283.50 Crore.
• Yearly revenue consistently increased from Rs 5,419.99 Crore in 2021 to Rs 8,939.59 Crore in 2025, though net profit varied.
• The company commenced commercial production at its new Hingani, Wardha manufacturing unit.
• Ipca Laboratories announced multiple dividends and underwent a stock split in January 2022.